Caribou Biosciences, Inc. (CRBU)
0.4602
-0.02
(-4.36%)
USD |
NASDAQ |
Oct 09, 16:00
0.4601
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Cash from Operations (Quarterly) : -22.79M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.79M |
| March 31, 2026 | -26.98M |
| December 31, 2025 | -20.82M |
| September 30, 2025 | -25.18M |
| June 30, 2025 | -28.26M |
| March 31, 2025 | -36.72M |
| December 31, 2024 | -35.47M |
| September 30, 2024 | -32.66M |
| June 30, 2024 | -32.87M |
| March 31, 2024 | -37.20M |
| December 31, 2023 | -21.38M |
| September 30, 2023 | -28.79M |
| June 30, 2023 | -15.18M |
| Date | Value |
|---|---|
| March 31, 2023 | -27.94M |
| December 31, 2022 | -25.04M |
| September 30, 2022 | -22.38M |
| June 30, 2022 | -21.87M |
| March 31, 2022 | -21.67M |
| December 31, 2021 | -21.39M |
| September 30, 2021 | -14.97M |
| June 30, 2021 | -16.48M |
| March 31, 2021 | 20.31M |
| December 31, 2020 | -8.076M |
| September 30, 2020 | -8.691M |
| June 30, 2020 | -7.205M |
| March 31, 2020 | -9.243M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -83.11M |
| Vir Biotechnology, Inc. | 123.33M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.28M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 18.94M |
| Cash from Financing (Quarterly) | 17.94M |
| Free Cash Flow | -95.75M |
| Free Cash Flow Per Share (Quarterly) | -0.2257 |
| Free Cash Flow to Equity (Quarterly) | -22.50M |
| Free Cash Flow to Firm (Quarterly) | -22.79M |
| Free Cash Flow Yield | -216.4% |